Last price paid | 0.015 | |
Change | -25.00% [ -0.01 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 03.05.2024 17:20 |
Fixing | 21.06.2024 |
Settlement date | 11.10.2023 |
Last trading | 21.06.2024 |
Final fixing | 21.06.2024 |
Currency redemption | CHF |
Perf. since issue | -88.89% |
Year to date (YTD) | -50.00% |
1 month | n.a. |
3 months | -62.50% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.09 |
Underlying price on issue | 87.81 |
Premium | 0.10% |
Premium p.a. | 1.24% |
Leverage | 40.00 |
Implied volatility | 0.21 |
ISIN | CH1281033030 |
Symbol | NOVUVZ |
Security | 128103303 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | 28.06.2024 |
Underlying | Novartis N, CH0012005267 |
Underlying ISIN | CH0012005267 |
Strike | 100.00 |
C/P type | call |
Subscription ratio | 15.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | American |
Delivery of securities | On Demand |
Minimum execution | 15 |
Value day | 04.10.2023 |
Premium | 10.23% |
Premium p.a. | 124.41% |
Leverage | 648.93 |
Implied volatility | 20.95% |
Moneyness | out-of-the-money |
Leverage | 40.0041 |
Delta | 0.0616 |
Gamma | 0.0016 |
Theta | -0.0008 |
Rho | 0.0003 |
Vega | 0.0022 |
Fair value | 0.01 |
Intrinsic value | n.a. |
Break-even | 100.14 |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Warrant (2100) |
Name | Price |
---|---|
Swiss Re | 112.95 |
ROCHE GS | 230.60 |
Givaudan | 4'233.00 |
ABB Ltd | 49.74 |
SONOVA HLDG N | 289.10 |
Name | Price |
---|---|
Lonza Group | 485.10 |
UBS | 28.00 |
Partners Group Ho... | 1'196.00 |
Swiss Life Hldg | 625.60 |
LOGITECH INT. | 86.36 |